SEC Filing Summary: Colfax Corporation (10-Q)
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Colfax Corporation (Note: The input metadata listed "Enovis CORP," but the document text explicitly identifies the registrant as Colfax Corporation). The report covers the quarter and six months ended July 2, 2010. Colfax is a global supplier of fluid handling products, including pumps, systems, and valves, serving commercial marine, oil and gas, power generation, defense, and general industrial markets.
Key Financial Metrics
All figures in thousands, except per share data.
| Metric | Three Months Ended July 2, 2010 | Six Months Ended July 2, 2010 |
|---|---|---|
| Net Sales | $122,968 | $242,939 |
| Gross Profit | $42,981 (35.0% margin) | $84,737 (34.9% margin) |
| Operating Income | $4,834 (3.9% margin) | $5,727 (2.4% margin) |
| Net Income | $2,038 | $1,385 |
| Diluted EPS | $0.05 | $0.03 |
| Cash and Equivalents | $62,974 (as of July 2, 2010) | N/A |
| Operating Cash Flow (6mo) | N/A | $27,435 |
| Total Debt (Current + Long-term) | $87,500 | $87,500 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4.8% in the quarter and 8.5% for the six-month period compared to the prior year. This was driven by a 3.1% (quarter) and 10.3% (six-month) decline in sales from existing businesses due to lower demand in oil and gas, commercial marine, and power generation markets.
- Profitability Compression: Operating income fell 41.7% in the quarter and 71.5% for the six-month period. The decline was primarily due to lower sales volumes, unfavorable product mix shifts, and increased restructuring charges.
- Restructuring Costs: The company recorded $3.0 million in restructuring charges for the quarter and $7.1 million for the six months ended July 2, 2010, compared to $0.5 million and $1.1 million in the prior year periods. These costs included $2.2 million in termination benefits related to the departure of the former CEO.
- Asbestos Litigation: Asbestos coverage litigation expenses increased to $4.5 million for the quarter and $8.4 million for the six months, up from $4.0 million and $7.0 million in the prior year, due to trial costs.
Outlook, Risks, and Management Commentary
- Market Outlook: Management expects orders to increase significantly in 2010 across most markets, though sales are expected to decline modestly in commercial marine and power generation. The defense market is expected to see significant sales growth.
- Order Backlog: Backlog stood at $297.1 million as of July 2, 2010, a decrease of 3.2% from the prior year, excluding currency and acquisition impacts. However, backlog increased 11.6% since April 2, 2010.
- Liquidity: The company maintains approximately $135.9 million available on its revolver loan and $63.0 million in cash. It is in compliance with all debt covenants.
- Key Risks: Significant risks include the uncertainty of asbestos-related liabilities and insurance recoveries, foreign currency exchange rate fluctuations (68% of sales are outside the U.S.), and the cyclical nature of the company's end markets.
Investor Verification Checklist
- Asbestos Liability Accuracy: Verify the $445.9 million liability reserve and the $392.0 million insurance asset, noting the company expects to be responsible for approximately 10-14% of future costs.
- Restructuring Execution: Monitor the realization of cost savings from the restructuring program initiated in 2009 and the completion of the $1.0 million in expected additional termination benefits for 2010.
- Order Conversion: Track the conversion of the reported 30.6% increase in orders (quarterly) into actual revenue, given the history of order cancellations in the commercial marine sector.
- Currency Impact: Assess the sensitivity of future earnings to the Euro and Swedish Krona, given that 67-68% of sales are derived from non-U.S. operations.